Clincosm LogoSign in Get a demo

Prurigo Nodularis

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prurigo Nodularis Trial (Dupilumab SAR231893 (REGN668))

Not yet recruiting
  • Prurigo Nodularis
  • Dupilumab SAR231893 (REGN668)
  • (no location specified)
Oct 11, 2023

Dupilumab in Prurigo Nodularis: An Observational Study

Not yet recruiting
  • Prurigo Nodularis
  • (no location specified)
Aug 7, 2023

Prurigo Nodularis Trial (Ruxolitinib Cream, Vehicle Cream)

Not yet recruiting
  • Prurigo Nodularis
  • Ruxolitinib Cream
  • Vehicle Cream
  • (no location specified)
Mar 1, 2023

Prurigo Nodularis Trial in Worldwide (Nalbuphine ER Tablets, Matching Placebo Tablets)

Active, not recruiting
  • Prurigo Nodularis
  • Nalbuphine ER Tablets
  • Matching Placebo Tablets
  • Phoenix, Arizona
  • +69 more
Jan 31, 2023

Prurigo Nodularis, Pruritis Trial in Worldwide (vixarelimab, Placebo)

Active, not recruiting
  • Prurigo Nodularis
  • Pruritis
  • Anniston, Alabama
  • +76 more
Jan 3, 2023

Prurigo Nodularis Trial in Germany, United States (CDX-0159, Normal saline)

Recruiting
  • Prurigo Nodularis
  • CDX-0159
  • Normal saline
  • Tempe, Arizona
  • +18 more
Jan 4, 2023

Prurigo Nodularis Trial in Worldwide (INCB054707, Placebo)

Recruiting
  • Prurigo Nodularis
  • Phoenix, Arizona
  • +48 more
Dec 1, 2022

Prurigo Nodularis Trial in Austria, United States (Nemolizumab, Placebo)

Recruiting
  • Prurigo Nodularis
  • Irvine, California
  • +4 more
Aug 12, 2022

Prurigo Nodularis Trial in Worldwide (Nemolizumab 30 mg, Placebo)

Recruiting
  • Prurigo Nodularis
  • Nemolizumab 30 mg
  • Placebo
  • Birmingham, Alabama
  • +109 more
Jun 29, 2022

China Type II Inflammatory Skin Disease Clinical Research and

Recruiting
  • Atopic Dermatitis Eczema
  • Prurigo Nodularis
    • Beijing, China
      Peking University First Hospital
    Mar 29, 2022

    Pruritus, Prurigo Nodularis Trial in United States (5mg Serlopitant Tablets, Placebo Tablets)

    Completed
    Has Results
    • Pruritus
    • Prurigo Nodularis
    • 5mg Serlopitant Tablets
    • Placebo Tablets
    • Birmingham, Alabama
    • +48 more
    May 18, 2021

    Prurigo Nodularis Trial in Germany (serlopitant, Placebo)

    Completed
    Has Results
    • Prurigo Nodularis
    • Berlin-Mitte, Germany
    • +14 more
    May 18, 2021

    Pruritus, Prurigo Nodularis Trial in Austria, Germany, Poland (5mg Serlopitant Tablets, Placebo Tablets)

    Completed
    Has Results
    • Pruritus
    • Prurigo Nodularis
    • 5mg Serlopitant Tablets
    • Placebo Tablets
    • Graz, Austria
    • +39 more
    May 18, 2021

    Pruritus, Prurigo Nodularis, Atopic Dermatitis Trial in Worldwide (5 mg Serlopitant Tablets)

    Terminated
    Has Results
    • Pruritus
    • +3 more
    • 5 mg Serlopitant Tablets
    • Birmingham, Alabama
    • +84 more
    May 18, 2021

    Keloid, Alopecia Areata, Acne Trial in Nashville (Corticosteroid with lidocaine, Corticosteroid with normal saline)

    Completed
    Has Results
    • Keloid
    • +14 more
    • Corticosteroid with lidocaine
    • Corticosteroid with normal saline
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Feb 18, 2021

    Transcriptomic Landscape of T Lymphocytes of Atopic Dermatitis,

    Unknown status
    • Prurigo Nodularis
    • Atopic Dermatitis
    • Skin biopsy
    • Plastic surgery remnants
    • (no location specified)
    Feb 6, 2021

    Prurigo Nodularis, Nodularis Prurigo, Prurigo Trial in Germany, Poland, United States (nalbuphine HCl ER tablets 90 mg BID,

    Completed
    Has Results
    • Prurigo Nodularis
    • +3 more
    • nalbuphine HCl ER tablets 90 mg BID
    • +2 more
    • Cleveland, Ohio
    • +3 more
    Oct 5, 2020

    Prurigo Nodularis, Nodularis Prurigo, Prurigo Trial in Münster (nalbuphine HCl ER)

    Completed
    Has Results
    • Prurigo Nodularis
    • +2 more
    • nalbuphine HCl ER
    • Münster, Germany
      University of Münster
    Oct 5, 2020

    Prurigo Nodularis Trial in Worldwide (CD14152 Dose A, CD14152 )

    Completed
    Has Results
    • Prurigo Nodularis
    • CD14152 Dose A
    • CD14152 placebo
    • Graz, Austria
    • +15 more
    Feb 7, 2020

    Prurigo Nodularis Trial in Hellerup (Apremilast Oral Product)

    Unknown status
    • Prurigo Nodularis
    • Apremilast Oral Product
    • Hellerup, Denmark
      Department of Dermato-Allergology
    Jul 2, 2018

    Prurigo Nodularis Trial in Cleveland (CC-10004)

    Completed
    Has Results
    • Prurigo Nodularis
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center
    Sep 27, 2016

    Prurigo Nodularis Trial in Münster (Pimecrolimus, Hydrocortisone)

    Completed
    • Prurigo Nodularis
    • Münster, Germany
      Department of Dermtology, University of Münster
    Jul 6, 2010

    Prurigo Nodularis Trial in Jerusalem (citalopram (cipralex))

    Unknown status
    • Prurigo Nodularis
    • citalopram (cipralex)
    • Jerusalem, Israel
      : Hadassah Medical Organization,
    Sep 19, 2007